​Last updated on 03 July 2025

In line with the Ministry of Health’s efforts to enhance preventive care, a new National Familial Hypercholesterolaemia (FH) Genetic Testing Programme has been introduced to support early identification of patients with FH, with effect from 30 June 2025.

FH is an inherited genetic condition causing impaired LDL-cholesterol (LDL-C) metabolism and predisposes to early onset atherosclerotic cardiovascular disease (ASCVD). Early detection of FH through LDL-C screening, gene testing, and cascade screening is crucial for managing FH and reducing the lifetime risk of ASCVD and death.



The following resources may be useful to you:​

​MOH Circular No. 33/2025 Introduction of Familial Hypercholesterolaemia (FH) Genetic Testing Service

​Click here to download

​MOH Circular No. 36/2025 Key Amendments to The Moratorium on Genetic Testing and Insurance

​Click here to download

​Familial Hypercholesterolaemia Genetic Testing Service: A Guide for Primary Care Providers 

​Click here​ to download

​Familial Hypercholesterolaemia Brochures

​Genomic Assessment Centre (GAC) Leaflet

​Genetic Testing, Insurance and the Moratorium: What You Should Know Pamphlet​

English version



Since 30 June 2025, doctors can refer Singapore Citizens (SC) or Permanent Residents (PR) to the Genomic Assessment Centre (GAC) @ SingHealth*, if they meet the criteria of LDL-C ≥ 5.5 mmol/L (≥ 212mg/dL).

*This GAC will serve all Singapore Residents (Singapore Citizens and Permanent Residents) until the GACs operated by NUHS and NHG open subsequently.

For further clarification on MOH Circulars relating to Familial Hypercholesterolaemia Genetic Testing Service, please email moh_info@moh.gov.sg

For further clarification on the Moratorium on Genetic Testing and Insurance, please email HCSA_Enquiries@moh.gov.sg.​